Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check18 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.3, replacing the previous version v2.16.2. The estimated last update posted has been removed.SummaryDifference0.1%
- Check26 days agoChange DetectedThe page has been updated to reflect that it is now active and not recruiting, with a new last update date of June 5, 2025, and a revision to version 2.16.2. Several contact details for study personnel have been removed.SummaryDifference5%
- Check33 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check40 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.